GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Cyclically Adjusted PB Ratio

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Cyclically Adjusted PB Ratio : 1.48 (As of Apr. 30, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio?

As of today (2024-04-30), Shanghai Fosun Pharmaceutical (Group) Co's current share price is HK$12.32. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was HK$8.34. Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio for today is 1.48.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

HKSE:02196' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.75   Med: 4.56   Max: 8.83
Current: 1.93

During the past years, Shanghai Fosun Pharmaceutical (Group) Co's highest Cyclically Adjusted PB Ratio was 8.83. The lowest was 1.75. And the median was 4.56.

HKSE:02196's Cyclically Adjusted PB Ratio is ranked worse than
53.46% of 651 companies
in the Drug Manufacturers industry
Industry Median: 1.76 vs HKSE:02196: 1.93

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted book value per share data for the three months ended in Dec. 2023 was HK$18.698. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$8.34 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.16 5.84 4.76 3.10 2.04

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.10 2.79 2.62 2.36 2.04

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio falls into.



Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=12.32/8.34
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=18.698/114.6694*114.6694
=18.698

Current CPI (Dec. 2023) = 114.6694.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Book Value per Share CPI Adj_Book
201403 8.501 98.600 9.886
201406 8.305 98.200 9.698
201409 9.166 98.900 10.627
201412 9.038 99.000 10.469
201503 9.417 99.900 10.809
201506 9.456 99.500 10.898
201509 9.237 100.500 10.539
201512 9.443 100.600 10.764
201603 9.648 102.200 10.825
201606 9.668 101.400 10.933
201609 9.448 102.400 10.580
201612 10.304 102.600 11.516
201703 10.639 103.200 11.821
201706 11.324 103.100 12.595
201709 12.170 104.100 13.406
201712 12.028 104.500 13.199
201803 12.892 105.300 14.039
201806 12.436 104.900 13.594
201809 12.725 106.600 13.688
201812 12.400 106.500 13.351
201903 13.105 107.700 13.953
201906 12.718 107.700 13.541
201909 13.165 109.800 13.749
201912 13.845 111.200 14.277
202003 14.126 112.300 14.424
202006 14.108 110.400 14.654
202009 14.689 111.700 15.079
202012 17.112 111.500 17.598
202103 17.542 112.662 17.855
202106 17.846 111.769 18.309
202109 18.310 112.215 18.710
202112 18.726 113.108 18.985
202203 18.440 114.335 18.494
202206 17.471 114.558 17.488
202209 18.231 115.339 18.125
202212 18.631 115.116 18.559
202303 19.349 115.116 19.274
202306 18.608 114.558 18.626
202309 18.431 115.339 18.324
202312 18.698 114.669 18.698

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Fosun Pharmaceutical (Group) Co  (HKSE:02196) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shanghai Fosun Pharmaceutical (Group) Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines